English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 107 Help

Selected(0)Clear Items/Page:    Sort:
Uncover the anticancer potential of lycorine Journal article
Zhang, Yan Ming, Li, Ting, Xu, Chun Cao, Qian, Jia Yu, Guo, Hongwei, Zhang, Xiaolei, Zhan, Zha Jun, Lu, Jin Jian. Uncover the anticancer potential of lycorine[J]. Chinese Medicine (United Kingdom), 2024, 19(1), 121.
Authors:  Zhang, Yan Ming;  Li, Ting;  Xu, Chun Cao;  Qian, Jia Yu;  Guo, Hongwei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/10/10
Anticancer Mechanism  Lycorine  Lycorine Hydrochloride  Pharmacokinetics  Target  
Unlocking daidzein's healing power: Present applications and future possibilities in phytomedicine Journal article
Goleij, Pouya, Sanaye, Pantea Majma, Alam, Waqas, Zhang, Junmin, Tabari, Mohammad Amin Khazeei, Filosa, Rosanna, Jeandet, Philippe, Cheang, Wai San, Efferth, Thomas, Khan, Haroon. Unlocking daidzein's healing power: Present applications and future possibilities in phytomedicine[J]. Phytomedicine, 2024, 134, 155949.
Authors:  Goleij, Pouya;  Sanaye, Pantea Majma;  Alam, Waqas;  Zhang, Junmin;  Tabari, Mohammad Amin Khazeei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.7/6.2 | Submit date：2024/10/10
Anti-metastatic  Anticancer  Antioxidant  Apoptosis  Cell Cycle Arrest  Daidzein  
Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies Review article
2024
Authors:  Lin, Ziqi;  Assaraf, Yehuda G.;  Kwok, Hang Fai
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:7.7/10.3 | Submit date：2024/08/05
Anticancer Agents  Microbe- And Virus-induced Cancers  Microbial And Viral Infections  Peptide-based Therapeutics  
Emerging anticancer potential and mechanisms of snake venom toxins: A review Journal article
Guo, Xijun, Fu, Yuanfeng, Peng, Junbo, Fu, Ying, Dong, Shuai, Ding, Ren Bo, Qi, Xingzhu, Bao, Jiaolin. Emerging anticancer potential and mechanisms of snake venom toxins: A review[J]. International Journal of Biological Macromolecules, 2024, 269.
Authors:  Guo, Xijun;  Fu, Yuanfeng;  Peng, Junbo;  Fu, Ying;  Dong, Shuai; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:7.7/7.7 | Submit date：2024/07/04
Angiogenesis  Anticancer  Cell proliferation  Invasion and migration  Programmed cell death  Snake venom toxins  
Emerging anticancer potential and mechanisms of snake venom toxins: A review Review article
2024
Authors:  Guo, Xijun;  Fu, Yuanfeng;  Peng, Junbo;  Fu, Ying;  Dong, Shuai; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:7.7/7.7 | Submit date：2024/05/16
Angiogenesis  Anticancer  Cell Proliferation  Invasion And Migration  Programmed Cell Death  Snake Venom Toxins  
Supramolecular systems for bioapplications: recent research progress in China Journal article
Liu, Yue Yang, Yu, Xiao Yong, Pan, Yu Chen, Yin, Hang, Chao, Shuang, Li, Yujie, Ma, He, Zuo, Minzan, Teng, Kun Xu, Hou, Jun Li, Chen, Yong, Guo, Dong Sheng, Wang, Ruibing, Pei, Yuxin, Pei, Zhichao, Xu, Jiang Fei, Hu, Xiao Yu, Li, Chunju, Yang, Qing Zheng, Wang, Leyong, Liu, Yu, Li, Zhan Ting. Supramolecular systems for bioapplications: recent research progress in China[J]. Science China Chemistry, 2024, 67(5), 1397-1441.
Authors:  Liu, Yue Yang;  Yu, Xiao Yong;  Pan, Yu Chen;  Yin, Hang;  Chao, Shuang; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:10.4/7.9 | Submit date：2024/05/16
Anticancer And Antibacterial  Antidote  Bioimaging And Biosensing  Drug Delivery  Host-guest Chemistry  Photodynamic Therapy  Photothermal Therapy  Transmembrane Channel  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Biological potential and mechanisms of Tea's bioactive compounds: An Updated review Journal article
Luo, Qiaoxian, Luo, Longbiao, Zhao, Jinmin, Wang, Yitao, Luo, Hua. Biological potential and mechanisms of Tea's bioactive compounds: An Updated review[J]. Journal of Advanced Research, 2023, 65, 345 - 363.
Authors:  Luo, Qiaoxian;  Luo, Longbiao;  Zhao, Jinmin;  Wang, Yitao;  Luo, Hua
Favorite | TC[WOS]:16 TC[Scopus]:20  IF:11.4/11.0 | Submit date：2024/02/22
Anticancer  Antioxidant  Bioactivities  Pharmacological Effects  Tea  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells Journal article
Zhang, Keqiang, Sun, Ting, Li, Wendong, Guo, Yuming, Li, Aimin, Hsieh, Marcus, Wang, Jinghan, Wu, Jun, Arvanitis, Leonidas, Raz, Dan J.. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells[J]. Cell Communication and Signaling, 2023, 21, 319.
Authors:  Zhang, Keqiang;  Sun, Ting;  Li, Wendong;  Guo, Yuming;  Li, Aimin; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.0 | Submit date：2024/01/02
C-myc  Deubiquitinase  P53  Sp1  Targeted Anticancer Therapy  Usp22  Usp7